NCT01836159

Brief Summary

A pilot randomized, two parallel group study comparing an iPad software game application versus standard care in post-stroke patients. Study hypothesis: Tablet PC technology using the iPad is a feasible and potentially efficacious tool which has the potential to promote fine motor recovery of the upper extremity after stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 19, 2013

Completed
1.1 years until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

October 1, 2019

Status Verified

September 1, 2019

Enrollment Period

2.8 years

First QC Date

April 16, 2013

Last Update Submit

September 30, 2019

Conditions

Keywords

Stroke RehabilitationiPadFine Motor FunctionIschemic StrokeVisual Neglect

Outcome Measures

Primary Outcomes (1)

  • Total "dose" of intervention received as a proportion of the scheduled time

    The maximum total dose of intervention is 200min (20 min/day x 10 days). A 70% received intervention (≥140 min) from the total scheduled time will be considered successful. This will be measured by the amount of time the patient uses the application (this data is stored in the application).

    10 days over a 2 week period

Secondary Outcomes (1)

  • Efficacy in fine motor function skills

    3 business days after final study intervention session

Study Arms (2)

Standard/ Usual Care

OTHER

Patients may receive outpatient rehabilitation as required as part of usual/standard care. No experimental intervention will be given to this group.

Other: Standard/ Usual Care

iPad Intervention

EXPERIMENTAL

Patients randomized to the iPad arm will be instructed to self-administer 20 minutes of game sessions per day for 10 days over a 2 week (14 day) period.

Other: iPad Intervention

Interventions

Patients are to self-administer 20 minutes of gaming sessions, in any configuration that is preferred. Patients will be instructed to play the iPad game with the more affected arm/hand. Start and stop times of the iPad intervention will be downloaded from the iPad, which will allow calculation of the total "dose" received. Patients may receive outpatient rehabilitation as required as part of usual care. The 'Stroke Rehab' software for the iPad was specifically designed for patients with either fine motor weakness and/or neglect. It contains 6 stages: 1. Popping a stationary balloon 2. Popping a moving balloon 3. Popping a pair of stationary balloons 4. Popping a pair of moving balloons 5. Stretching a balloon to pop 6. Balloon/Text distraction test

iPad Intervention

Patients may receive outpatient rehabilitation as required as part of usual care. Patients will be instructed not to play with an iPad during the 2 week intervention period (in case they have one).

Standard/ Usual Care

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has provided written consent prior to entry into the study
  • Males or females, 18 - 85 years of age
  • Evidence of ischemic or hemorrhagic stroke confirmed by CT or MRI head scan
  • Patient with onset of symptoms less than 3 months (for iHOME Acute) or patient more than 6 months (for iHOME Chronic) at the time of randomization
  • Measurable deficit of the upper extremity ≥3 according to the Chedoke McMaster scale e.g. participants should be able to touch their chin and contralateral knee to be eligible (for iHome Acute), or measurable deficit of the upper extremity ≥4 according to the Chedoke McMaster scale e.g. participants should be able to touch their chin and contralateral knee to be eligible (for iHome Chronic)
  • Functional independence prior to present stroke (mRS = 0-1)
  • Patient is alert, medically stable according to the treating physician and able to follow simple verbal commands

You may not qualify if:

  • Patient had stroke onset more than 3 months ago (for iHOME Acute) or patient had stroke onset less than 6 months ago (for iHOME Chronic)
  • Inability to follow verbal commands or having global aphasia
  • Severe illness with life expectancy less than 3 months
  • Uncontrolled hypertension, unstable angina, or recent myocardial infarction
  • History of seizures
  • Participation in another clinical trial involving rehabilitation or investigational drug
  • Unable to comply with the protocol
  • Any medical condition that might confound the interpretation of results or put the patient at risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Toronto Rehabilitation Institute

Toronto, Ontario, M5G 2A2, Canada

Location

Related Publications (1)

  • Saposnik G, Chow CM, Gladstone D, Cheung D, Brawer E, Thorpe KE, Saldanha A, Dang A, Bayley M, Schweizer TA; iHOME Research Team for the Stroke Outcomes Research Canada Working Group. iPad technology for home rehabilitation after stroke (iHOME): a proof-of-concept randomized trial. Int J Stroke. 2014 Oct;9(7):956-62. doi: 10.1111/ijs.12328. Epub 2014 Jul 7.

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Tom Schweizer, PhD

    Li Ka Shing, St Michael's Hospital

    STUDY DIRECTOR
  • Chi-Ming Chow, MD

    Unity Health Toronto

    STUDY DIRECTOR
  • Gustavo Saposnik, MD, MSc

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2013

First Posted

April 19, 2013

Study Start

June 1, 2014

Primary Completion

March 1, 2017

Study Completion

March 1, 2018

Last Updated

October 1, 2019

Record last verified: 2019-09

Locations